Juan-Miguel Bergua (Jordi Esteve, Juan Miguel Bergua, Juan Miguel Bergua Burgues, J Bergua, Juan Bergua)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Blood advances

Leukemia & lymphoma

Blood cancer journal

British journal of haematology

Hospital San Pedro de Alcántara

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital San Pedro de Alcántara Mar 18 2008

Spain

Chair :: Hematology

Hospital San Pedro de Alcántara Jan 14 1993 - Mar 18 2008

Spain

Adjunto :: Hematology

Publications

Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia. Blood advances (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Esperanza Martin-Sanchez, Laura Blanco-Fernández, Peter S Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús San F Miguel, Ana Alfonso, Juan-Miguel Bergua, Rebeca Rodriguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Juan José Lahuerta, Aintzane Zabaleta
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia. Blood advances 8 (15) (2024)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Catia Simoes, Sara Villar, Beñat Ariceta, Juan-José Garcés, Leire Burgos, Diego Alignani, Sarai Sarvide, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez-Lorenzo, Maria-Belen Vidriales, Carmen Chillon, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa María Ayala, Joaquin Martinez Lopez, Ana Alfonso Pierola, María-José Calasanz, Felipe Prosper, Jesús San F Miguel, Miguel Á Sanz, Juan José Lahuerta, Pau Montesinos, null null
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia. British journal of haematology (2023)
Alejandro Martin Martin Garcia-Sancho, M Baile, G Rodríguez, Ivan Dlouhy, Juan-Manuel Sancho, I Jarque, E González-Barca, A Salar, M Espeso, C Grande, Juan-Miguel Bergua, S Montes-Moreno, A Redondo, A Enjuanes, E Campo, Armondo López-Guillermo, D Caballero
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO. British journal of haematology (2023)
David Belada, Katerina Kopeckova, Juan-Miguel Bergua, Don Stevens, Marc André, Ernesto Perez Persona, Petra Pichler, Philipp Bernhard Staber, Marek Trněný, Johannes Duell, Maeve Waldron-Lynch, Steve Wagner, Amitava Mukhopadhyay, Maren Dirnberger-Hertweck, John M Burke, Grzegorz S Nowakowski
Safety and efficacy of tafasitamab ± lenalidomide added to first-line R‑CHOP for DLBCL: Phase 1b First-MIND study. Blood (2023)
Josep-María Ribera, Olga García, Buenaventura Buendía-Ureña, Maria-José Terol, Ana Vicent, Ferran Vall-Llovera, Juan-Miguel Bergua, Irene García-Cadenas, Aleksandra Holowiecka, Jordi Ribera, Evelyn Acuña-Cruz, Pilar Herrera, Jesus-Maria Hernández-Rivas, Pau Abrisqueta, José González-Campos, Carlos Rodríguez, Mariana Bastos-Oreiro, Eulàlia Genescà, Nerea Caminos, Maria-Paz Queipo de Llano, Antònia Cladera, Juan-Manuel Sancho, null null
Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain. Leukemia & lymphoma 63 (8) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
David Martínez-Cuadrón, Juan Eduardo Megías-Vericat, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Cristina Gil, Eliana Aguiar, Juan-Miguel Bergua, Jose L Lopez-Lorenzo, Teresa Bernal, Ana Espadana, Mercedes Colorado, Carlos Rodríguez-Medina, María López-Pavia, Mar Tormo, Jesus Lorenzo Algarra, Maria Luz Amigo, Maria Jose Sayas, Jorge Labrador, Juan I Rodríguez-Gutiérrez, Celina Benavente Cuesta, Lissette Costilla-Barriga, Raimundo García-Boyero, Esperanza Lavilla-Rubira, Susana Vives, Pilar Herrera, Daniel García Belmonte, María Mar Herráez-Albendea, Graça V Esteves, María Isabel Gómez-Roncero, Ana Cabello, Guiomar Bautista, Amaia Balerdi, José Mário Mariz, Blanca Boluda, Miguel A Sanz, Pau Montesinos
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study. Blood advances (2021)
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, David W Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin, David Belada, Juan-Miguel Bergua, Francesco A Piazza, Heidi Mócikova, Anna Lia Molinari, Dok Hyun Yoon, Federica Cavallo, Monica Tani, Kazuhito Yamamoto, Koji Izutsu, Koji Kato, Myron Czuczman, Sarah Hersey, Adrian Kilcoyne, Jacqueline Russo, Krista Hudak, Jingshan Zhang, Steve Wade, Thomas E Witzig, Umberto Vitolo
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Tomás Palanques-Pastor, Juan Eduardo Megías-Vericat, Pilar Martínez, José Luis López Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez Macias, Isabel Cano, Montserrat Arnan Sangerman, María Belén Vidriales Vicente, Jesús Lorenzo Algarra Algarra, María Ángeles Foncillas, Pilar Herrera, Carmen Botella Prieto, Susana Vives, Ángela Figuera Álvarez, Laida Cuevas Palomares, Marta Anna Sobas, Alejandro Contento Gonzalo, Rebeca Cuello García, María Elena Amutio Diez, Dunia De Miguel Llorente, Begoña Navas Elorza, Juan-Miguel Bergua, Teresa Bernal Del Castillo, María Carmen Mateos Rodríguez, Erik de Cabo López, Ana Carolina Franco Villegas, Raimundo García Boyero, Cristian Escolano Escobar, Cristina Seri Merino, Carlos Cervero, Alicia Roldán Pérez, Lourdes Hermosín Ramos, Marta Cervera Calvo, María Telesa Olave, Paola Villafuerte Gutiérrez, Almudena de Laiglesiai, Josefina Serrano, María Josefa Najera Irazu, José Luis Piñana, Miguel Ángel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. Leukemia & lymphoma 62 (12) (2021)
David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, Mar Tormo, Pilar Martínez-Sánchez, José A Pérez-Simón, Raimundo García-Boyero, Carlos Rodríguez-Medina, María López-Pavía, Celina Benavente, Juan-Miguel Bergua, Esperanza Lavilla-Rubira, María-Luz Amigo, Pilar Herrera, Juan Manuel Alonso-Domínguez, Teresa Bernal Del Castillo, Mercedes Colorado, María J Sayas, Lorenzo Algarra, Maria Vidriales Vicente, Gabriela Rodríguez-Macías, Susana Vives, Manuel Mateo Pérez Encinas, Aurelio López, Víctor Noriega, María García-Fortes, Fernando Ramos, Juan I Rodríguez-Gutiérrez, Lisette Costilla-Barriga, Jorge Labrador, Blanca Boluda, Rebeca Rodriguez-Veiga, Joaquin Martinez Lopez, Miguel Angel Sanz, Pau Montesinos
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? Leukemia 35 (6) (2020)
Jorge Labrador, Elisa Luño, Edo Vellenga, Salut Brunet, José González-Campos, María Carmen Chillón, Aleksandra Holowiecka, Juan-Miguel Bergua, Juan Bergua, José D González-Sanmiguel, Cristina Gil, María Del Mar Tormo Díaz, Olga Salamero, Felix Manso, Isolda I Fernández, Javier de laSerna, María-José Moreno, Manuel Pérez-Encinas, Isabel Krsnik, Josep-María Ribera, Jose Cervera, María J Calasanz, Blanca Boluda, Marta Anna Sobas, Bob Löwenberg, Miguel A Sanz, Pau Montesinos
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy. Leukemia & lymphoma 60 (5) (2018)

Juan-Miguel Bergua.css-eqlu8i{font-size:small;padding-left:4px;} (Jordi Esteve, Juan Miguel Bergua, Juan Miguel Bergua Burgues, J Bergua, Juan Bergua)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan-Miguel Bergua (Jordi Esteve, Juan Miguel Bergua, Juan Miguel Bergua Burgues, J Bergua, Juan Bergua)